Catalysts for $MDGL
5 tracked
May 6, 2026
earnings
MADRIGAL PHARMACEUTICALS, INC. earnings
MADRIGAL PHARMACEUTICALS, INC.
→
Dec 19, 2025
approval
REZDIFFRA (RESMETIROM) — FDA approval
resmetirom
→
Dec 19, 2025
approval
REZDIFFRA (RESMETIROM) — FDA approval
resmetirom
→
Dec 19, 2025
approval
REZDIFFRA (RESMETIROM) — FDA approval
resmetirom
→
Mar 14, 2024
approval
REZDIFFRA (RESMETIROM) — FDA approval
resmetirom
→